Skip to content Skip to footer
Subscribe Now
The US FDA New Drug Approvals in September 2024
INSIGHTS+

The US FDA New Drug Approvals in September 2024

Shots:     PharmaShots has compiled a list of US FDA-approved drugs in the month of September 2024     The US FDA has approved a total of 7 new drugs including 4 new molecular entities and 3 biologics leading to the treatment of patients and advances in the healthcare industry       The major highlighted drugs were Roche’s Tecentriq Hybreza & Ocrevus Zunovo for…
October 22, 2024

Read more

Roche
NEWS

Roche’s Tecentriq Hybreza Receives the US FDA’s Approval for Cancer Treatment 

  Shots:   The US FDA has approved Tecentriq Hybreza (SC) to treat all IV indications, incl. lung, liver, skin & soft tissue cancers. Regulatory reviews across other regions are underway The approval was supported by P-IB/III (IMscin001) study assessing Tecentriq Hybreza (SC) vs Tecentriq (IV) in locally advanced or metastatic NSCLC patients (n=371) failed on…
September 13, 2024

Read more